Emi Takashita Selected Research

peramivir

7/2022	Antiviral Susceptibilities of Avian Influenza A(H5), A(H7), and A(H9) Viruses Isolated in Japan.
9/2020	Detection of a Peramivir-Resistant Influenza B/Yamagata-Lineage Virus Imported from Indonesia in Aichi, Japan, March 2019.
7/2020	Successful treatment with baloxavir marboxil of a patient with peramivir-resistant influenza A/H3N2 with a dual E119D/R292K substitution after allogeneic hematopoietic cell transplantation: a case report.
1/2016	Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015.
5/2015	Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014.
5/2015	Characterization of a large cluster of influenza A(H1N1)pdm09 viruses cross-resistant to oseltamivir and peramivir during the 2013-2014 influenza season in Japan.
10/2014	Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emi Takashita Research Topics

Disease

34	Human Influenza (Influenza) 07/2022 - 09/2004
12	Infections 07/2022 - 01/2009
4	Virus Diseases (Viral Diseases) 02/2022 - 12/2011
3	COVID-19 10/2022 - 01/2022
2	Disease Progression 11/2021 - 07/2020
2	Fever (Fevers) 11/2021 - 03/2010
1	Influenza in Birds (Avian Flu) 07/2022
1	Leukemia 07/2020
1	Lymphopenia (Lymphocytopenia) 07/2020
1	Herpesviridae Infections (Herpesvirus Infection) 01/2018
1	Bell Palsy (Bell's Palsy) 01/2007
1	Parkinson Disease (Parkinson's Disease) 09/2006

Drug/Important Bio-Agent (IBA)

17	Neuraminidase (Sialidase)IBA 07/2022 - 07/2011
14	Antiviral Agents (Antivirals)IBA 10/2022 - 01/2007
14	baloxavirIBA 07/2022 - 01/2018
10	Oseltamivir (Tamiflu)FDA Link 07/2022 - 03/2010
7	peramivirIBA 07/2022 - 10/2014
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2004
6	Zanamivir (Relenza)FDA Link 07/2022 - 03/2010
5	VaccinesIBA 02/2022 - 06/2012
5	EndonucleasesIBA 01/2022 - 01/2018
4	laninamivirIBA 07/2022 - 10/2014
3	favipiravirIBA 07/2022 - 01/2016
3	Pharmaceutical PreparationsIBA 10/2021 - 10/2015
2	AntibodiesIBA 10/2022 - 01/2020
2	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 07/2022 - 01/2016
2	molnupiravirIBA 02/2022 - 01/2022
2	N-methyl-valyl-amiclenomycin (BA 2)IBA 02/2022 - 01/2022
2	N-(2-cyanoethylene)urea (BA 1)IBA 02/2022 - 01/2022
2	nirmatrelvirIBA 02/2022 - 01/2022
2	COV2-2130IBA 02/2022 - 01/2022
2	COV2-2196IBA 02/2022 - 01/2022
2	Monoclonal AntibodiesIBA 02/2022 - 01/2022
2	Prednisolone (Predate)FDA LinkGeneric 07/2020 - 01/2007
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2020
2	Hemagglutinins (Hemagglutinin)IBA 01/2018 - 09/2004
1	Amantadine (Aman)FDA LinkGeneric 07/2022
1	pimodivirIBA 01/2021
1	RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA 01/2021
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2020
1	Viral RNAIBA 01/2016
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 12/2015
1	CREB-Binding ProteinIBA 12/2015
1	6SLN-lipo PGAIBA 10/2015
1	Neutralizing AntibodiesIBA 12/2011
1	Indicators and Reagents (Reagents)IBA 12/2011
1	NucleoproteinsIBA 01/2009
1	Staphylococcal Protein A (Protein A)IBA 08/2007
1	Therapeutic UsesIBA 01/2007
1	Valacyclovir (Valtrex)FDA LinkGeneric 01/2007
1	G-Protein-Coupled Receptor Kinase 5IBA 09/2006
1	OligosaccharidesIBA 09/2004
1	Biological ProductsIBA 09/2004

Therapy/Procedure

2	Therapeutics 12/2012 - 01/2007
1	Cell Transplantation 07/2020
1	Aftercare (After-Treatment) 01/2020